US Stock MarketDetailed Quotes
NRBO NeuroBo Pharmaceuticals
- 3.0200
- -0.1000-3.21%
Close Apr 23 16:00 ET
- 3.0100
- -0.0100-0.33%
Post 16:16 ET
14.82MMarket Cap-1227P/E (TTM)
3.1900High2.9900Low42.19KVolume3.1000Open3.1200Pre Close128.44KTurnover0.90%Turnover RatioLossP/E (Static)4.91MShares6.749952wk High0.89P/B14.24MFloat Cap2.888852wk Low--Dividend TTM4.71MShs Float129539.9482Historical High--Div YieldTTM6.41%Amplitude2.8880Historical Low3.0430Avg Price1Lot Size
NeuroBo Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -32.76%22.44M | -32.76%22.44M | 306.50%25.84M | 224.19%28.69M | 166.62%30.81M | 103.60%33.36M | 103.60%33.36M | -8.99%6.36M | -6.98%8.85M | -11.34%11.56M |
| -Cash and cash equivalents | -32.76%22.44M | -32.76%22.44M | 306.50%25.84M | 224.19%28.69M | 166.62%30.81M | 103.60%33.36M | 103.60%33.36M | -8.99%6.36M | -6.98%8.85M | -11.34%11.56M |
| Prepaid assets | --13K | --13K | -64.14%308K | -60.42%486K | -60.75%670K | --0 | --0 | 5.79%859K | 55.64%1.23M | 105.42%1.71M |
| Current deferred assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --339K | ---- | ---- |
| Other current assets | -61.90%64K | -61.90%64K | ---- | ---- | ---- | --168K | --168K | ---- | ---- | ---- |
| Total current assets | -32.86%22.51M | -32.86%22.51M | 246.11%26.15M | 189.51%29.17M | 137.36%31.48M | 102.19%33.53M | 102.19%33.53M | -3.70%7.55M | -3.74%10.08M | -4.53%13.26M |
| Non current assets | ||||||||||
| Net PPE | 12,300.00%248K | 12,300.00%248K | 8,533.33%259K | 0.00%5K | -97.46%5K | -99.07%2K | -99.07%2K | -98.71%3K | -98.01%5K | -25.94%197K |
| -Gross PPE | 840.00%282K | 840.00%282K | 863.33%289K | 13.33%34K | -89.38%34K | -90.80%30K | -90.80%30K | -90.96%30K | -91.12%30K | -6.16%320K |
| -Accumulated depreciation | -21.43%-34K | -21.43%-34K | -11.11%-30K | -16.00%-29K | 76.42%-29K | 74.77%-28K | 74.77%-28K | 72.73%-27K | 71.26%-25K | -64.00%-123K |
| Other non current assets | --21K | --21K | --21K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current assets | 13,350.00%269K | 13,350.00%269K | 9,233.33%280K | 0.00%5K | -97.46%5K | -99.07%2K | -99.07%2K | -98.71%3K | -98.01%5K | -25.94%197K |
| Total assets | -32.07%22.78M | -32.07%22.78M | 249.68%26.43M | 189.42%29.18M | 133.92%31.49M | 99.62%33.53M | 99.62%33.53M | -6.44%7.56M | -5.94%10.08M | -4.94%13.46M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 127.40%1.61M | 127.40%1.61M | 84.28%1.98M | 45.63%967K | 44.20%1.12M | -14.70%708K | -14.70%708K | 12.80%1.08M | 91.35%664K | 65.81%776K |
| -accounts payable | 15.96%821K | 15.96%821K | 84.28%1.98M | 45.63%967K | 44.20%1.12M | -14.70%708K | -14.70%708K | 12.80%1.08M | 91.35%664K | 65.81%776K |
| -Due to related parties current | --789K | --789K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Current accrued expenses | 1,194.64%3.63M | 1,194.64%3.63M | 196.69%1.61M | 248.89%2.04M | -39.83%417K | -78.48%280K | -78.48%280K | -41.00%544K | -27.87%585K | 53.32%693K |
| Current debt and capital lease obligation | --67K | --67K | --65K | ---- | ---- | ---- | ---- | ---- | ---- | 12.50%27K |
| -Current capital lease obligation | --67K | --67K | --65K | ---- | ---- | --0 | --0 | --0 | --0 | 12.50%27K |
| Other current liabilities | -93.91%658K | -93.91%658K | --1.06M | --975K | --9.44M | --10.8M | --10.8M | ---- | ---- | ---- |
| Current liabilities | -49.42%5.96M | -49.42%5.96M | 191.66%4.72M | 218.90%3.98M | 633.96%10.98M | 446.31%11.78M | 446.31%11.78M | -14.83%1.62M | 5.58%1.25M | 58.47%1.5M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | --136K | --136K | --153K | ---- | ---- | --0 | --0 | --0 | --0 | -43.08%37K |
| -Long term capital lease obligation | --136K | --136K | --153K | ---- | ---- | --0 | --0 | --0 | --0 | -43.08%37K |
| Total non current liabilities | --136K | --136K | --153K | --0 | --0 | --0 | --0 | --0 | --0 | -43.08%37K |
| Total liabilities | -48.27%6.1M | -48.27%6.1M | 201.11%4.88M | 218.90%3.98M | 616.24%10.98M | 435.15%11.78M | 435.15%11.78M | -17.06%1.62M | 0.64%1.25M | 51.93%1.53M |
| Shareholders'equity | ||||||||||
| Share capital | -80.00%5K | -80.00%5K | 3,700.00%38K | 40.74%38K | 0.00%27K | 2,400.00%25K | 2,400.00%25K | -95.45%1K | 22.73%27K | 22.73%27K |
| -common stock | -80.00%5K | -80.00%5K | 3,700.00%38K | 40.74%38K | 0.00%27K | 2,400.00%25K | 2,400.00%25K | -95.45%1K | 22.73%27K | 22.73%27K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -13.02%-108.27M | -13.02%-108.27M | -12.99%-102.95M | -12.64%-99.13M | -16.17%-98.4M | -17.07%-95.8M | -17.07%-95.8M | -17.95%-91.12M | -19.27%-88.01M | -21.23%-84.7M |
| Paid-in capital | 6.32%124.95M | 6.32%124.95M | 28.24%124.46M | 28.38%124.29M | 23.06%118.88M | 21.88%117.52M | 21.88%117.52M | 16.45%97.06M | 16.30%96.81M | 16.40%96.6M |
| Gains losses not affecting retained earnings | --0 | --0 | ---- | ---- | ---- | --0 | --0 | --0 | --0 | -57.14%3K |
| Total stockholders'equity | -23.29%16.69M | -23.29%16.69M | 262.92%21.55M | 185.25%25.2M | 71.93%20.51M | 49.00%21.75M | 49.00%21.75M | -3.05%5.94M | -6.81%8.83M | -9.30%11.93M |
| Total equity | -23.29%16.69M | -23.29%16.69M | 262.92%21.55M | 185.25%25.2M | 71.93%20.51M | 49.00%21.75M | 49.00%21.75M | -3.05%5.94M | -6.81%8.83M | -9.30%11.93M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg